326 related articles for article (PubMed ID: 31595378)
1. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.
Al Shweiki MR; Steinacker P; Oeckl P; Hengerer B; Danek A; Fassbender K; Diehl-Schmid J; Jahn H; Anderl-Straub S; Ludolph AC; Schönfeldt-Lecuona C; Otto M
J Psychiatr Res; 2019 Jun; 113():137-140. PubMed ID: 30953863
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of serum NfL and p-Tau
Benussi A; Karikari TK; Ashton N; Gazzina S; Premi E; Benussi L; Ghidoni R; Rodriguez JL; Emeršič A; Simrén J; Binetti G; Fostinelli S; Giunta M; Gasparotti R; Zetterberg H; Blennow K; Borroni B
J Neurol Neurosurg Psychiatry; 2020 Sep; 91(9):960-967. PubMed ID: 32611664
[TBL] [Abstract][Full Text] [Related]
4. Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.
Cajanus A; Katisko K; Kontkanen A; Jääskeläinen O; Hartikainen P; Haapasalo A; Herukka SK; Vanninen R; Solje E; Hall A; Remes AM
Ann Clin Transl Neurol; 2020 Jun; 7(6):903-910. PubMed ID: 32441885
[TBL] [Abstract][Full Text] [Related]
5. The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.
Das S; van Engelen ME; Goossens J; Jacobs D; Bongers B; Fieldhouse JLP; Pijnenburg YAL; Teunissen CE; Vanmechelen E; Verberk IMW
Alzheimers Res Ther; 2024 Feb; 16(1):34. PubMed ID: 38355535
[TBL] [Abstract][Full Text] [Related]
6. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
8. Clinical Accuracy of Serum Neurofilament Light to Differentiate Frontotemporal Dementia from Primary Psychiatric Disorders is Age-Dependent.
Light V; Jones SL; Rahme E; Rousseau K; de Boer S; Vermunt L; Soltaninejad M; Teunissen C; Pijnenburg Y; Ducharme S; Consortium FS
Am J Geriatr Psychiatry; 2024 Mar; ():. PubMed ID: 38609836
[TBL] [Abstract][Full Text] [Related]
9. Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.
Eratne D; Kang M; Malpas C; Simpson-Yap S; Lewis C; Dang C; Grewal J; Coe A; Dobson H; Keem M; Chiu WH; Kalincik T; Ooi S; Darby D; Brodtmann A; Hansson O; Janelidze S; Blennow K; Zetterberg H; Walker A; Dean O; Berk M; Wannan C; Pantelis C; Loi SM; Walterfang M; Berkovic SF; Santillo AF; Velakoulis D
Aust N Z J Psychiatry; 2024 Jan; 58(1):70-81. PubMed ID: 37477141
[TBL] [Abstract][Full Text] [Related]
10. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
[TBL] [Abstract][Full Text] [Related]
11. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Rojas JC; Wang P; Staffaroni AM; Heller C; Cobigo Y; Wolf A; Goh SM; Ljubenkov PA; Heuer HW; Fong JC; Taylor JB; Veras E; Song L; Jeromin A; Hanlon D; Yu L; Khinikar A; Sivasankaran R; Kieloch A; Valentin MA; Karydas AM; Mitic LL; Pearlman R; Kornak J; Kramer JH; Miller BL; Kantarci K; Knopman DS; Graff-Radford N; Petrucelli L; Rademakers R; Irwin DJ; Grossman M; Ramos EM; Coppola G; Mendez MF; Bordelon Y; Dickerson BC; Ghoshal N; Huey ED; Mackenzie IR; Appleby BS; Domoto-Reilly K; Hsiung GR; Toga AW; Weintraub S; Kaufer DI; Kerwin D; Litvan I; Onyike CU; Pantelyat A; Roberson ED; Tartaglia MC; Foroud T; Chen W; Czerkowicz J; Graham DL; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; Galimberti D; Rowe JB; Masellis M; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Cash DM; Convery RS; Bocchetta M; Foiani M; Greaves CV; Peakman G; Russell L; Swift I; Todd E; Rohrer JD; Boeve BF; Rosen HJ; Boxer AL;
Neurology; 2021 May; 96(18):e2296-e2312. PubMed ID: 33827960
[TBL] [Abstract][Full Text] [Related]
12. Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration.
Benussi A; Cantoni V; Rivolta J; Archetti S; Micheli A; Ashton N; Zetterberg H; Blennow K; Borroni B
Alzheimers Res Ther; 2022 Oct; 14(1):155. PubMed ID: 36229847
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
Oeckl P; Steinacker P; Feneberg E; Otto M
J Neurochem; 2016 Aug; 138 Suppl 1():184-92. PubMed ID: 27186717
[TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
[TBL] [Abstract][Full Text] [Related]
15. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance.
Katisko K; Cajanus A; Huber N; Jääskeläinen O; Kokkola T; Kärkkäinen V; Rostalski H; Hartikainen P; Koivisto AM; Hannonen S; Lehtola JM; Korhonen VE; Helisalmi S; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E; Haapasalo A
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1305-1312. PubMed ID: 34187866
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
[TBL] [Abstract][Full Text] [Related]
18. ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.
Cousins KAQ; Phillips JS; Irwin DJ; Lee EB; Wolk DA; Shaw LM; Zetterberg H; Blennow K; Burke SE; Kinney NG; Gibbons GS; McMillan CT; Trojanowski JQ; Grossman M
Alzheimers Dement; 2021 May; 17(5):822-830. PubMed ID: 33226735
[TBL] [Abstract][Full Text] [Related]
19. Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers.
Casaletto KB; Kornack J; Paolillo EW; Rojas JC; VandeBunte A; Staffaroni AS; Lee S; Heuer H; Forsberg L; Ramos EM; Miller BL; Kramer JH; Yaffe K; Petrucelli L; Boxer A; Boeve B; Gendron TF; Rosen H;
JAMA Neurol; 2023 Jan; 80(1):82-90. PubMed ID: 36374516
[TBL] [Abstract][Full Text] [Related]
20. Neurofilaments as Emerging Biomarkers of Neuroaxonal Damage to Differentiate Behavioral Frontotemporal Dementia from Primary Psychiatric Disorders: A Systematic Review.
Davy V; Dumurgier J; Fayosse A; Paquet C; Cognat E
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33922390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
